CGEM
Cullinan Oncology Inc
Price:  
12.52 
USD
Volume:  
385,798.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CGEM WACC - Weighted Average Cost of Capital

The WACC of Cullinan Oncology Inc (CGEM) is 9.5%.

The Cost of Equity of Cullinan Oncology Inc (CGEM) is 15.30%.
The Cost of Debt of Cullinan Oncology Inc (CGEM) is 5.00%.

Range Selected
Cost of equity 13.30% - 17.30% 15.30%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 8.5% - 10.5% 9.5%
WACC

CGEM WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 2.05 2.23
Additional risk adjustments 0.0% 0.5%
Cost of equity 13.30% 17.30%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 8.5% 10.5%
Selected WACC 9.5%